Global DNA Testing/Diagnostics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Instruments, Reagents Service, and Software

By Technology;

PCR, Microarray, Sequencing Technology, Mass Spectrometry, and Others

By Test Type;

Genetic Testing and Diagnostic Testing

By Sample Type;

Blood and Saliva

By Application;

Pre-Natal DNA Carrier Screening, Pre-Implantation Diagnosis, New-Born Genetic Screening, Infectious Disease Diagnostics - (HBV Diagnostics, HCV Diagnostics, HIV Diagnostics, TB Diagnostics, CT/NG Diagnostics, HPV Diagnostics, MRSA Diagnostics & Other Diagnostics), Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, Pharmacogenomics Diagnostic Testing, Drug Metabolism & P450 Effects, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn860374769 Published Date: May, 2025 Updated Date: June, 2025

Introduction

Global DNA Testing/Diagnostics Market (USD Million), 2021 - 2031

DNA Testing/Diagnostics Market was valued at USD 14,334.65 million in the year 2024. The size of this market is expected to increase to USD 28,345.61 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.2%.


Global DNA Testing/Diagnostics Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 10.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)10.2 %
Market Size (2024)USD 14,334.65 Million
Market Size (2031)USD 28,345.61 Million
Market ConcentrationLow
Report Pages387
14,334.65
2024
28,345.61
2031

Major Players

  • 454 Life Sciences
  • Abbott Laboratories
  • Affymetrix Inc
  • Agilent Technologies Inc
  • Applied Biosystems Group
  • Thermo Fisher Scientific Inc
  • Illumina Inc
  • Cepheid Inc
  • Hologic
  • Bio-Rad Laboratories

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global DNA Testing/Diagnostics Market

Fragmented - Highly competitive market without dominant players


The DNA Testing/Diagnostics Market is witnessing rapid growth, driven by the rising demand for genetic testing for disease prediction and precise diagnostics. Nearly 60% of these tests are performed to assess genetic risks and diagnose hereditary conditions, highlighting the shift toward personalized medicine and preventive healthcare. This trend is supported by increasing awareness of the genetic basis of diseases, encouraging more proactive healthcare decisions.

Technological Advancements in DNA Testing
Breakthroughs in DNA sequencing technologies have significantly transformed genetic diagnostics, making tests faster and more accurate. Advanced methods like next-generation sequencing (NGS) and polymerase chain reaction (PCR) now account for nearly 40% of the market, reflecting their growing importance in clinical practice. These innovations have enhanced the precision of genetic analysis, reducing turnaround times and improving diagnostic accuracy.

Preventive Healthcare Applications on the Rise
Genetic testing is also gaining traction in preventive healthcare, with nearly 35% of tests focusing on early disease detection and carrier screening. This proactive strategy is reducing the prevalence of genetic disorders, enhancing patient quality of life, and minimizing the long-term costs associated with chronic conditions.

Supportive Healthcare Policies and Growing Awareness
Governments and healthcare organizations are actively promoting the integration of genetic diagnostics into routine care. Currently, over 45% of healthcare programs include genetic screening as a core component, reflecting a broader push toward personalized and precision healthcare. This supportive regulatory environment is expected to drive further market growth.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Test Type
    4. Market Snapshot, By Sample Type
    5. Market Snapshot, By Application
    6. Market Snapshot, By Region
  4. Global DNA Testing/Diagnostics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Demand for Personalized Medicine
        2. Rising Prevalence of Genetic Disorders
        3. Government Initiatives and Funding
        4. Expansion of Direct-to-Consumer (DTC) Testing
      2. Restraints
        1. Concerns over genetic data privacy
        2. Regulatory hurdles across regional markets
        3. High cost of advanced DNA tests
        4. Ethical issues surrounding genetic predictions
      3. Opportunities
        1. Development of point-of-care DNA diagnostics
        2. Integration with cloud-based genetic databases
        3. Expansion into forensic and paternity testing
        4. Use in targeted and precision medicine
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global DNA Testing/Diagnostics Market, By Product Type, 2021 - 2031 (USD Million)
      1. Instruments
      2. Reagents Service
      3. Software
    2. Global DNA Testing/Diagnostics Market, By Technology, 2021 - 2031 (USD Million)
      1. PCR, Microarray
      2. Sequencing Technology
      3. Mass Spectrometry
      4. Others
    3. Global DNA Testing/Diagnostics Market, By Test Type, 2021 - 2031 (USD Million)
      1. Genetic Testing
      2. Diagnostic Testing
    4. Global DNA Testing/Diagnostics Market, By Sample Type, 2021 - 2031 (USD Million)
      1. Blood
      2. Saliva
    5. Global DNA Testing/Diagnostics Market, By Application, 2021 - 2031 (USD Million)
      1. Pre-Vatal DNA Carrier Screening
      2. Pre-Vmplantation Diagnosis
      3. New-Born Genetic Screening
      4. Infectious Disease Diagnostics
        1. HBV Diagnostics
        2. HCV Diagnostics
        3. HIV Diagnostics
        4. TB Diagnostics
        5. CT/NG Diagnostics
        6. HPV Diagnostics
        7. MRSA Diagnostics
        8. Other Diagnostics
      5. Oncology Diagnostics & Histopathology
      6. Identity Diagnostics & Forensics
      7. Pharmacogenomics Diagnostic Testing
      8. Drug Metabolism & P450 Effects
      9. Others
    6. Global DNA Testing/Diagnostics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. 454 Life Sciences
      2. Abbott Laboratories
      3. Affymetrix Inc
      4. Agilent Technologies Inc
      5. Applied Biosystems Group
      6. Thermo Fisher Scientific Inc
      7. Illumina Inc
      8. Cepheid Inc
      9. Hologic
      10. Bio-Rad Laboratories
  7. Analyst Views
  8. Future Outlook of the Market